| # | Drug | Count |
|---|---|---|
| 0 | RIVASTIGMINE | 27 |
| 1 | FUROSEMIDE | 17 |
| 2 | AMLODIPINE | 16 |
| 3 | PREDNISOLONE | 16 |
| 4 | PREDNISOLONE ORAL | 16 |
| 5 | PREDNISOLONE ORAL SOLUTION | 16 |
| 6 | WARFARIN | 15 |
| 7 | CYCLOPHOSPHAMIDE | 14 |
| 8 | CYCLOPHOSPHAMIDE FOR INJECTION | 14 |
| 9 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 14 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | XENON | 1 | 0.0769 |
| 1 | CAFFEINE, MAGNESIUM SALICYLATE | 1 | 0.0039 |
| 2 | QUAZEPAM | 1 | 0.0033 |
| 3 | PAMABROM | 1 | 0.0027 |
| 4 | PALIFERMIN | 1 | 0.0026 |
| 5 | RIVASTIGMINE TARTRATE | 1 | 0.0022 |
| 6 | AMOXAPINE | 1 | 0.0021 |
| 7 | MOMETASONE FUROATE MONOHYDRATE | 1 | 0.0020 |
| 8 | ALLOPURINOL SODIUM | 1 | 0.0018 |
| 9 | SUCCINYLCHOLINE CHLORIDE | 4 | 0.0018 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 34 |
| 1 | Cholinesterase Inhibitor [EPC] | 27 |
| 2 | Proton Pump Inhibitor [EPC] | 21 |
| 3 | Dihydropyridine Calcium Channel Blocker [EPC] | 18 |
| 4 | Loop Diuretic [EPC] | 17 |
| 5 | Calcium Channel Blocker [EPC] | 16 |
| 6 | Alkylating Drug [EPC] | 15 |
| 7 | Angiotensin 2 Receptor Blocker [EPC] | 15 |
| 8 | Nonsteroidal Anti-inflammatory Drug [EPC] | 15 |
| 9 | Histamine-2 Receptor Antagonist [EPC] | 14 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Inhalation Diagnostic Agent [EPC] | 1 | 0.0769 |
| 1 | Mucocutaneous Epithelial Cell Growth Factor [EPC] | 1 | 0.0026 |
| 2 | Tricyclic Antidepressant [EPC] | 1 | 0.0021 |
| 3 | Cholinesterase Inhibitor [EPC] | 27 | 0.0014 |
| 4 | Claudin 18.2-directed Cytolytic Antibody [EPC] | 1 | 0.0007 |
| 5 | Osmotic Diuretic [EPC] | 3 | 0.0006 |
| 6 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 3 | 0.0005 |
| 7 | Anthelmintic [EPC] | 1 | 0.0003 |
| 8 | CD33-directed Immunoconjugate [EPC] | 1 | 0.0003 |
| 9 | Sulfonamide Antibacterial [EPC] | 1 | 0.0003 |